Monocyte-derived macrophages were co-infected with human immunodeficiency virus (HIV), strain HIVBa-L, and human cytomegalovirus (HCMV) strain AD 169. HCMV enhanced the production of p24 antigen and infectious HIV, but HIV had no effect on HCMV production. In dually infected cultures HIV p24 antigen levels were increased 5- to 15-fold during the first 3 weeks of culture. This enhancement was observed both for cell-associated and extracellular p24 antigen from co-infected cells. The replication of macrophage-tropic clinical isolates of HIV were also enhanced by HCMV, but HCMV did not enable T cell-tropic viruses to replicate in macrophages. Conversely, HCMV clinical isolates from blood or urine were able to upregulate HIV production. Similar enhancement of HIV p24 antigen levels was observed with noninfectious, heat-inactivated HCMV, indicating that replication of HCMV in the macrophages was not necessary. Although replication was not required, the enhancing ability of HCMV was associated with the virus. Enhancement of HIV segregated with the HCMV pelleted virus particles and not the supernatant in stock virus. The fact that HCMV and HIV are detected in macrophages in persons with HIV infection highlights the importance of this system for studying interactions between HIV and HCMV in persons with HIV infection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/viro.1994.1101 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The feasibility and impact of deploying a four-tests panel at antenatal care in primary health care facilities of a developing country, Kenya.
Front Public Health
December 2024
Centre for Biotechnology Research Development (CBRD), Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Introduction: Contracting HIV, syphilis, hepatitis B virus (HBV), and malaria during pregnancy significantly affects the health of the woman, the pregnancy, and the unborn child. The World Health Organization (WHO) recommends testing pregnant women for these infections to achieve triple elimination of mother-to-child transmissions. However, this goal has not been fully realized in low- to medium-income countries, primarily due to segmented testing practices.
View Article and Find Full Text PDFTMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.
J Immunother Cancer
November 2024
Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands
Article Synopsis
- The study explores how the PD-1 immune checkpoint protein is regulated on CD8 T cells, aiming to find ways to lower its abundance without hindering T cell activation, which is crucial for effective cancer therapy.
- Researchers conducted a CRISPR-Cas9 screen on murine CD8 T cells to identify genes impacting PD-1 levels, discovering that inhibiting the TMED protein family, especially TMED10, could reduce PD-1 on the cell surface and enhance T cell function.
- The findings highlight a new regulatory mechanism for PD-1 and suggest that targeting TMED could be a promising therapeutic strategy to improve T cell responses in cancer treatment, as indicated by correlations in mouse models and patient survival data.
Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of extracts and Shatavarin IV.
Front Microbiol
October 2024
Division of Virology, ICMR - National Institute of Translational Virology and AIDS Research, Pune, India.
Article Synopsis
- AR, an Ayurvedic botanical, was studied for its effects on HIV-1 replication and its ability to reduce mitochondrial dysfunction during infection.
- Both AR root extracts and its main active compound, Shatavarin IV, showed non-toxic, dose-dependent inhibition of HIV-1 in laboratory tests, particularly effective against certain viral subtypes.
- Shatavarin IV interacted with key enzymes involved in HIV-1 replication, suggesting its potential as a therapeutic agent, while also helping to alleviate mitochondrial damage caused by the virus.
Fourth-Generation HIV Rapid Tests: Enhanced Sensitivity and Reduced Diagnostic Window for HIV-1 Primary Infection Screening.
J Med Virol
November 2024
Laboratoire de Virologie, INSERM, Institut Pierre Louis d' Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Sorbonne Université, Paris, France.
Article Synopsis
- Most HIV rapid tests primarily detect antibodies, which makes them less effective in identifying early HIV infections.
- The Determine test, which includes p24-antigen detection, shows better overall sensitivity compared to the One-Step test, particularly during the early stages of infection.
- Using tests that detect p24-antigen can reduce the diagnostic window significantly, from around 3 months to about 1 month, but caution is advised when testing in the first month after infection.
Molecular sandwich-based DNAzyme catalytic reaction towards transducing efficient nanopore electrical detection of antigen proteins.
Faraday Discuss
October 2024
Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences & Chongqing School, The University of Chinese Academy of Sciences, Chongqing, 400714, China.
Despite significant advances in nanopore nucleic acid sequencing and sensing, protein detection remains challenging due to the inherent complexity of protein molecular properties (, net charges, polarity, molecular conformation & dimension) and sophisticated environmental parameters (, biofluids), resulting in unsatisfactory electrical signal resolution for protein detection such as poor accessibility, selectivity and sensitivity. The selection of an appropriate electroanalytical approach is strongly desired which should be capable of offering easily detectable and readable signals regarding proteins particularly depending on the practical application. Herein, a molecular sandwich-based cooperative DNAzyme catalytic reaction nanopore detecting approach was designed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!